Topics

A Study to Test GlaxoSmithKline's (GSK) Respiratory Syncytial Virus (RSV) Maternal Vaccine's Safety, Ability to Generate an Immune Response and Degree to Which the Vaccine Can Cause Side Effects in Healthy Non-pregnant Women After the Administration of th

2019-10-29 14:36:44 | BioPortfolio

Summary

The purpose of this study is to evaluate the safety, ability of GSK Biologicals' investigational RSV maternal vaccine (RSVPreF3) to generate an immune response and the degree to which the vaccine can cause side effects, when administered alone and in combination with Boostrix vaccine in healthy non-pregnant women 18-45 years of age. Two dose levels of RSVPreF3 and 2 Boostrix [Diphtheria, Tetanus and acellular Pertussis (dTpa) vaccine] formulations (US and ex-US) will be evaluated.

Description

Click here to enter text.

Study Design

Conditions

Respiratory Syncytial Virus Infections

Intervention

RSVPreF3 formulation 3, RSVPreF3 formulation 2, Boostrix-ex-US, Boostrix-US, Placebo

Location

GSK Investigational Site
Rochester
New York
United States
14609

Status

Not yet recruiting

Source

GlaxoSmithKline

Results (where available)

View Results

Links

Published on BioPortfolio: 2019-10-29T14:36:44-0400

Clinical Trials [2616 Associated Clinical Trials listed on BioPortfolio]

Study of Safety, Reactogenicity and Immunogenicity of GlaxoSmithKline's (GSK)Respiratory Syncytial Virus (RSV)Maternal Unadjuvanted Vaccine in Healthy Pregnant Women (Aged 18 to 40 Years) and Their Infants

The purpose of this study is to evaluate the safety and immune response to a single intramuscular (IM) dose of GSK Biologicals' investigational RSV maternal vaccine (RSVPreF3) in healthy p...

Evaluation of Boostrix™10 Years After Previous Booster Vaccination

The purpose of the study is to evaluate the immunogenicity, safety and reactogenicity of a dTpa booster dose given 10 years after the previous vaccination with dTpa in study 263855/029. On...

Evaluation of GSK Biologicals' Boostrix® Vaccine in Comparison With Decavac™ Vaccine.

This phase IIIb, observer-blind study will evaluate the immunogenicity and safety of GSK Biologicals' Boostrix® vaccine in adults (extending indication) aged 65 years or older.

Post-licensure, Modified Double-blind, Multi-center Study Evaluating Safety and Immunogenicity of ADACEL and BOOSTRIX

The study is observational and descriptive. To evaluate the safety and immunogenicity of ADACEL and BOOSTRIX vaccines among US adolescents.

The Safety of Boostrix Following Routine Immunization of Pregnant Women

The purpose of this study is to assess the safety of Boostrix administered on or after the first day of the 27th week of pregnancy by conducting a post-marketing study that will provide sa...

PubMed Articles [4754 Associated PubMed Articles listed on BioPortfolio]

Science and Art of Protein Formulation Development.

Protein pharmaceuticals have become a significant class of marketed drug products and are expected to grow steadily over the next decade. Development of a commercial protein product is, however, a rat...

Microsponges enriched gel for enhanced topical delivery of 5-Fluorouracil.

This study aimed to develop microsponges based topical gel formulation of 5-Fluorouracil (5-FU) for the treatment of skin cancer with enhanced skin deposition and reduced skin irritation potential. Mi...

Desmopressin and the risk of hyponatremia: A population-based cohort study.

Desmopressin was approved by the Food and Drug Administration (FDA) in 1978 for use in diabetes insipidus and bleeding disorders, but it is also prescribed off-label for patients with nocturia. Quanti...

The quaternary structure of insulin glargine and glulisine under formulation conditions.

The quaternary structures of insulin glargine and glulisine under formulation conditions and upon dilution using placebo or water were investigated using synchrotron small-angle X-ray scattering. Our ...

Pharmacokinetics and Bioequivalence of Memantine Tablet and a New Dry Syrup Formulation in Healthy Japanese Males: Two Single-Dose Crossover Studies.

Memantine hydrochloride, an N-methyl-D-aspartate receptor antagonist, is used to treat Alzheimer's disease (AD). A new dry syrup formulation containing memantine hydrochloride has been developed to im...

Medical and Biotech [MESH] Definitions

A type of viscous polysaccharide that is secreted from PLANTS. It has natural properties that are useful in the formulation of ADHESIVES.

A method of treating an ALLERGY by administering ALLERGENS, in liquid formulation or tablets, to the ORAL MUCOSA under the tongue.

Disorders in which phagocytic cells cannot kill ingested bacteria; characterized by frequent recurring infection with formulation of granulomas.

A field of biological research combining engineering in the formulation, design, and building (synthesis) of novel biological structures, functions, and systems.

Insulin formulation containing substance which delays or retards time period of the absorption of insulin.

More From BioPortfolio on "A Study to Test GlaxoSmithKline's (GSK) Respiratory Syncytial Virus (RSV) Maternal Vaccine's Safety, Ability to Generate an Immune Response and Degree to Which the Vaccine Can Cause Side Effects in Healthy Non-pregnant Women After the Administration of th"

Quick Search

Relevant Topics

Biotechnology Business
Alliances Astrazeneca Bioethics Boehringer Clinical Research Organization Collaborations GSK Johnson & Johnson Lilly Merck Mergers and Acquisitions Nexium Novartis Pfizer Roche Sanofi ...

Vaccines
A vaccine is any preparation intended to produce immunity to a disease by stimulating the production of antibodies. It creates immunity but does not cause the disease. There are several differnt types of vaccine avalable; Killed microorganisms; which s...


Searches Linking to this Trial